Human monoclonal antibodies against oxidized LDL receptor and medicinal use thereof

Details for Australian Patent Application No. 2006203702 (hide)

Owner Abgenix, Inc.

Inventors Tsuji, Hiroyuki; Sawamura, Tatsuya; Kamada, Masafumi; Kobayashi, Yuko

Agent Davies Collison Cave

Pub. Number AU-B-2006203702

Parent 784677

Filing date 25 August 2006

Wipo publication date 19 October 2006

Acceptance publication date 16 July 2009

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

14 September 2006 Complete Application Filed

19 October 2006 Application Open to Public Inspection

  Published as AU-B-2006203702

16 July 2009 Application Accepted

  Published as AU-B-2006203702

12 November 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006203703-Fence gate

2006203701-Method for installing an industrial piping system to resist corrosion